Q3 2025 Holdings
Filed 2025-11-14 | 43 holdings | $707.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $188.1M | 3,905,000 | 26.6% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $62.1M | 2,860,000 | 8.8% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $59.5M | 2,615,000 | 8.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $46.6M | 461,700 | 6.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $37.3M | 3,185,000 | 5.3% |
| Sanuwave Health Inc(SNWV) | COM | 80303D305 | $36.7M | 980,000 | 5.2% |
| Codexis Inc(CDXS) | COM | 192005106 | $31.2M | 12,795,000 | 4.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $19.3M | 535,000 | 2.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $18.6M | 1,595,000 | 2.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $16.5M | 410,000 | 2.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $16.0M | 682,017 | 2.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $14.4M | 363,257 | 2.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $13.5M | 450,000 | 1.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $12.8M | 193,773 | 1.8% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $11.3M | 585,000 | 1.6% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $10.6M | 3,720,867 | 1.5% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $9.8M | 255,087 | 1.4% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.5M | 903,442 | 1.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $8.4M | 987,818 | 1.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.1M | 500,000 | 1.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $7.9M | 2,600,000 | 1.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $7.2M | 2,725,000 | 1.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.0M | 105,000 | 1.0% |
| Journey Medical Corp(DERM) | COM | 48115J109 | $6.9M | 971,064 | 1.0% |
| SOL GEL Technologies(SLGL) | SHS NEW | M8694L137 | $6.0M | 204,835 | 0.8% |
| Protalix Biotherapeutics Inc(PLX) | COM | 74365A309 | $5.7M | 2,580,556 | 0.8% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $4.7M | 702,245 | 0.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.7M | 100,000 | 0.7% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $4.6M | $6,000,000 | 0.7% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $4.4M | 253,000 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.6M | 390,000 | 0.5% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.7M | 682,529 | 0.4% |
| Alumis Inc(ALMS) | COM | 022307102 | $2.7M | 665,000 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.9M | 808,882 | 0.3% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $1.8M | 1,100,000 | 0.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $1.7M | 100,000 | 0.2% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.1M | 65,000 | 0.2% |
| Rigel Pharmaceuticals(RIGL) | COM | 766559702 | $1.1M | 37,787 | 0.2% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $749.6K | 115,142 | 0.1% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $478.0K | 316,550 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $346.5K | 75,000 | 0.0% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $310.4K | 375,000 | 0.0% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $214.5K | 110,571 | 0.0% |